The design, which involves red, white and blue tiles, appears inside at least one subway station in Times Square. It’s one of many changes after Charlottesville.
NYS Entity Status
NYS Filing Date
MAY 30, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - DAPHNE CIRINO DESIGN CORP.
Around the Web
- M.T.A. to Modify Subway Station Design Resembling Confederate Flag
By MATT STEVENS - Friday Aug 18, 2017
- NY subway tiles with Confederate flag look to be altered
By TOM HAYS, Associated Press - Friday Aug 18, 2017
NEW YORK (AP) — Transit officials have decided to alter subway station tiles that have a cross-like design similar to that of the Confederate flag.The Metropolitan Transportation Authority is modifying the tiles at the 40th Street entrance to the Times Square subway stop to avoid any confusion about their meaning, MTA spokesman Kevin Ortiz said in a statement."These are not confederate flags" Ortiz said. The red, white and blue tiles installed decades ago are "based on geometric forms that represent the 'Crossroads of the World,'" he added.The decision comes in the wake of the deadly rally over a Robert E.
- Marine Corps Plane Crash: The Victims
By THE NEW YORK TIMES - Thursday Jul 13, 2017
Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.
- Does Electroconvulsive Therapy Improve Huntington’s Disease?
Wednesday Jul 19, 2017
For over 70 years Electroconvulsive Therapy (ECT) has been used to treat severe depression and there are reports that it could help patients with Huntington’s Disease who experience psychiatric symptoms. Many patients with Huntington’s Disease experience depression, with suicide rates 5 to 10 times higher than the general public. In 21 published case reports where -
- MSH3 Gene Reveals Critical Link With Huntington’s Disease
Wednesday Aug 9, 2017
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.